Regenerative Patch Technologies
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
150 Gabarda Way, Portola Valley, Califor...Phone Number
(650) 394-5835Website
www.regenerativepatch.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Regenerative Patch Technologies
Regenerative Patch Technologies, Inc is a California-based biotechnology company specializing in cell-based implant technology aimed at treating retinal diseases, particularly advanced dry age-related macular degeneration. Their lead product, the CPCB-RPE1 implant, is a bioengineered solution designed to replace damaged retinal pigmented epithelial cells and Bruchs membrane, which are critical for vision. The company is currently conducting a Phase IIb clinical trial to assess the safety and efficacy of this implant in patients with geographic atrophy. RPT's innovations are supported by significant funding from organizations like the California Institute for Regenerative Medicine, highlighting their commitment to advancing treatments for vision loss.Explore more
Regenerative Patch Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regenerative Patch Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Regenerative Patch Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Regenerative Patch Technologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Regenerative Patch Technologies recently announced quarterly report
Regenerative Patch Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Regenerative Patch Technologies
Funding: Get notified immidiatlly once Regenerative Patch Technologies has new funding data
Check if Regenerative Patch Technologies has recently received funding, and reach out quickly before it becomes old news!
Check out if Regenerative Patch Technologies is spiking on competitors!
Recommended Actions
Find VP level buyers at Regenerative Patch Technologies
Find 2 more new buyers
Compare Similar Companies to Regenerative Patch Technologies
Compare insights from companies similar to Regenerative Patch Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Regenerative Patch Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Regenerative Patch Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Regenerative Patch Technologies.
Regenerative Patch Technologies Tech Stack
A closer look at the technologies used by Regenerative Patch Technologies
See more technologies
Regenerative Patch Technologies News & Media
Regenerative Patch Technologies Presents Clinical Data Demonstrating Long-Term Survival and Function of an Allogenic Bioengineered Cellular Implant in Patients with Advanced Dry Aged-Related Macular Degeneration.
MENLO PARK, Calif., Feb. 4, 2022 /PRNewswire/ -- Regenerative Patch Technologies LLC (RPT) announced today the publication of results from its Phase 1/2a clinical trial of the CPCB-RPE1 implant for advanced, dry age-related macular degeneration. The publication entitled "Survival of an...Regenerative Patch Technologies Provides Update on Phase 1/2a Clinical Trial of Stem Cell-Engineered Implant for the Treatment of Dry Age-Related Macular Degeneration
MENLO PARK, Calif., June 28, 2021 /PRNewswire/ -- Regenerative Patch Technologies LLC (RPT) announced today the presentation of results from its Phase 1/2a clinical trial of the CPCB-RPE1 implant for advanced, dry age-related macular degeneration. The presentation entitled "Phase 1/2a...Regenerative Patch Technologies Announces Publication of Initial Results from Phase 1/2a Clinical Trial in Advanced Dry Age-Related Macular Degeneration
MENLO PARK, Calif., April 4, 2018 /PRNewswire/ -- Regenerative Patch Technologies LLC, a biotechnology company focused on the development of cell-based implant technology for the treatment of retinal diseases announced the publication of preliminary results from its Phase 1/2a clinical...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regenerative Patch Technologies
Sign Up For FreeTo access detailed company insights
Regenerative Patch Technologies, Inc is a California-based biotechnology company specializing in cell-based implant technology aimed at treating retinal diseases, particularly advanced dry age-related macular degeneration. Their lead product, the CPCB-RPE1 implant, is a bioengineered solution designed to replace damaged retinal pigmented epithelial... Read More
